Dynamic Susceptibility Contrast MRI for Evaluation of Patients with High-Grade Glioma: Need for Multicenter Clinical Trial Validation. Barboriak DP. AJR Am J Roentgenol 2025 May 28. doi: 10.2214/AJR.25.32940.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Barboriak DP. Dynamic Susceptibility Contrast MRI for Evaluation of Patients with High-Grade Glioma: Need for Multicenter Clinical Trial Validation. AJR Am J Roentgenol 2025 May 28. doi: 10.2214/AJR.25.32940.
PMID: 40434166